PI3K-IN-10

• UNSPSC Description:

  PI3K-IN-10 is a potent pan-PI3K inhibitor as a benzimidazole derivative, compound 332, extracted from patent WO2018057808A1[1].

• Target Antigen:

  PI3K

• Type:

  Reference compound

• Related Pathways:

  PI3K/Akt/mTOR

• Applications:

  Cancer-Kinase/protease

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/pi3k-in-10.html

• Solubility:

  10 mM in DMSO

• Smiles:

  ClC1=CC=CC(C1=NC=C2)=C2N(C=N3)C4=C3C(C5=CNC=N5)=CC(N6CCOCC6)=C4

• Molecular Weight:

  430.89

• References & Citations:

  [1]Jayaraman Chandrasekhar, et al. Benzimidazole derivatives and their use as phosphatidylinositol 3-kinase inhibitors. Patent WO2018057808A1.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  2211922-64-2